RxDoctor Payments Data

Sunil Ummat, MD

Otolaryngology · Kirkland, WANPI 1982675567

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,729 of the $2,552 with a category attached, or 67.8%. 16 manufacturers reported payments, led by Medical Device Business Services, Inc. at 34.8% of the total. Reporting peaked in 2022 at $1,078 and has fallen 71.5% since, to $308 in 2024.

$2,552in general payments, 2019–2025

Across 38 payments — averaging $67.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$888
  • Medtronic$485
  • Stryker$464
  • Alk-abello, Inc$169
  • Novo Nordisk$125
  • Galderma Laboratories, L.p.$92
  • plus $330 from 10 others

What the payments were for

  • Travel & lodging$81932%
  • Food & beverage$1,72968%
  • Gifts$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,552 in reported general payments places this provider in the 85th percentile of 254 otolaryngology providers in Washington.

See all otolaryngology providers in Washington

Medicare billing

Part B allowed, 2024
$165,773
Medicare patients
261
Services billed
3,022

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Olopatadine Hcl22$1,391
Ipratropium Bromide34$935
Azelastine Hcl42$877
Ofloxacin28$824
Omeprazole61$615
Mupirocin68$549
Fluticasone Propionate44$474
Gabapentin35$319
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$274
Doxycycline Monohydrate20$271
Sucralfate14$224
Ondansetron Hcl46$177
Cephalexin30$143
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$121
Levothyroxine Sodium20$65

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Kirkland

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →